Thierry Dorval,
Group Leader
Thierry Dorval received a B.S. degree in theoretical physic and graduated in image processing and artificial intelligence at the Pierre & Marie Curie University, Paris, France. He received a Ph.D. image analysis, indexing and retrieval and then joined the institut Pasteur Korea in 2005 first as researcher in biological image analysis then as a group leader specialized in High Content Screening applied to cellular differentiation as well as toxicity prediction. During this period of time he setup cellular assays in order to identify compounds modulating various stages of stem cell differentiation. He also worked on 3D cell cultures generated from induced pluripotent stem cells as model for teratogenicity and for toxicity prediction in general.
In 2012 he joined AstraZeneca, UK, where he was leading the Image and Data Analytics team. His activities were about developing and advising on quantitative image and data analysis solutions in support of high content phenotypic screens in addition to cellular and tissue imaging.
In 2015 he joined Servier, France, as leader of the High Content Screening group. He is currently still working on phenotypic approaches to improve drug discovery pipeline efficiency using high content strategies.
|
|
|
